Positioning a French Contract Development and Manufacturing Organisation as an innovative actor helping protect the country’s health sovereignty


The government’s reindustrialisation drive combined with requirement to relocate drug manufacturing in France have made contract pharmaceutical production a strategic activity, central to healthcare safety and sovereignty issues.

With the contract manufacturing market being highly competitive, our client’s challenge was to position itself to stand out in market segments offering high added value.

  • Ongoing consultancy and messaging designed to raise the profile of the client’s expertise, its innovative relationships with startups and pivotal role as part of France’s healthcare ecosystem.
  • Day-to-day operational support with press relations in the form of media training, organisation of one-on-one meetings with leading journalists, organisation of interviews and obtaining publication of op-ed articles.
  • Programme of institutional meetings to highlight our client’s contribution at regional and local levels.
  • Almost 100 press mentions in 2022.
  • The client’s managing director was listed by the media as an expert on the manufacturing aspects of healthcare.